
|Articles|July 11, 2017
Meropenem For Ceftazidime-Avibactam—Resistant K. pneumoniae
Researchers from the University of Pittsburgh find a way to successfully treat a patient with ceftazidime-avibactam-resistant Klebsiella pneumoniae.
Advertisement
Clinicians used meropenem to successfully treat a patient with bacteremia due to Klebsiella pneumoniae that carried a mutation in the blaKPC-3 gene, and was resistant to ceftazidime-avibactam.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contagion Live
1
Pritelivir Improves Outcomes in Immunocompromised Patients With Refractory Herpes Simplex Virus
2
Measles Update: February 6, 2026
3
Antibiotics Deconstructed: IV Fosfomycin
4
PASTEUR Act Reintroduced in Congress
5

































































































































